Stanford University
Palo Alto, California, United States
Internal Medicine resident at Stanford
1116: Second-line Therapy for Immune-checkpoint Inhibitor-induced Pneumonitis
Monday, October 27, 2025
10:30 AM - 12:30 PM Central Time
Disclosure(s): No financial relationships with ineligible companies to disclose
